Last reviewed · How we verify

NCT07121530

Human Papilloma Virus In Male Infertility

Completed Last updated 13 August 2025
What this trial tests

trial testing HPV infection in infertile males in Male Infertility in 50 participants. Completed in 10 August 2024.

Timeline
1 August 2023
Primary endpoint
1 August 2024
10 August 2024

Quick facts

Lead sponsorSouth Valley University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 August 2023
Primary completion1 August 2024
Estimated completion10 August 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

South Valley University

Who can join

Adults 23 to 53, male only, with Male Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Infertility is a major health problem worldwide and is estimated to affect 8-12% of couples in the reproductive age group. Infertility affects both men and women. Male causes for infertility are found in 50% of these couples. HPV may infect the semen ,allowing it to affect male fertility in a variety of ways.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Male Infertility

Currently open trials in the same condition.

Other South Valley University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07121530.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing